Movatterモバイル変換

[0]ホーム
URL:

SE9403833D0 - Analysis procedure and kit - Google Patents

Analysis procedure and kit

Info

Publication number
SE9403833D0
SE9403833D0SE9403833ASE9403833ASE9403833D0SE 9403833 D0SE9403833 D0SE 9403833D0SE 9403833 ASE9403833 ASE 9403833ASE 9403833 ASE9403833 ASE 9403833ASE 9403833 D0SE9403833 D0SE 9403833D0
Authority
SE
Sweden
Prior art keywords
pct
kit
sec
date
endothelial cells
Prior art date
Application number
SE9403833A
Other languages
Swedish (sv)
Inventor
Mats Raanby
Original Assignee
Global Hemostasis Inst Mgr Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Global Hemostasis Inst Mgr AbfiledCriticalGlobal Hemostasis Inst Mgr Ab
Priority to SE9403833ApriorityCriticalpatent/SE9403833D0/en
Publication of SE9403833D0publicationCriticalpatent/SE9403833D0/en
Priority to US08/817,830prioritypatent/US6156530A/en
Priority to JP8515252Aprioritypatent/JPH10509514A/en
Priority to EP95938102Aprioritypatent/EP0870200A1/en
Priority to PCT/SE1995/001324prioritypatent/WO1996014581A1/en

Links

Classifications

Landscapes

Abstract

PCT No. PCT/SE95/01324 Sec. 371 Date Aug. 11, 1997 Sec. 102(e) Date Aug. 11, 1997 PCT Filed Nov. 8, 1995 PCT Pub. No. WO96/14581 PCT Pub. Date May 17, 1996This invention relates to a method of analyzing coagulative, fibrinolytic or haemostatic activity in, especially, blood or plasma from mammals, particularly humans. The method comprises bringing a sample, in vitro, into contact with fixed and preferably from their growth support detached endothelial cells or outer membranes of such cells, and detecting the resulting coagulated material and, in some cases, lyzed coagulated material. Reagents are also described that are based on the endothelial cells and their outer membranes. A kit for performing such a method including the claimed reagent is also described.
SE9403833A1994-11-081994-11-08 Analysis procedure and kitSE9403833D0 (en)

Priority Applications (5)

Application NumberPriority DateFiling DateTitle
SE9403833ASE9403833D0 (en)1994-11-081994-11-08 Analysis procedure and kit
US08/817,830US6156530A (en)1994-11-081995-11-08Method for analysis of haemostatic activity
JP8515252AJPH10509514A (en)1994-11-081995-11-08 Methods, reagents and kits for analysis of hemostatic activity
EP95938102AEP0870200A1 (en)1994-11-081995-11-08Method, reagent and kit for analysis of haemostatic activity
PCT/SE1995/001324WO1996014581A1 (en)1994-11-081995-11-08Method, reagent and kit for analysis of haemostatic activity

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
SE9403833ASE9403833D0 (en)1994-11-081994-11-08 Analysis procedure and kit

Publications (1)

Publication NumberPublication Date
SE9403833D0true SE9403833D0 (en)1994-11-08

Family

ID=20395894

Family Applications (1)

Application NumberTitlePriority DateFiling Date
SE9403833ASE9403833D0 (en)1994-11-081994-11-08 Analysis procedure and kit

Country Status (5)

CountryLink
US (1)US6156530A (en)
EP (1)EP0870200A1 (en)
JP (1)JPH10509514A (en)
SE (1)SE9403833D0 (en)
WO (1)WO1996014581A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US5708591A (en)*1995-02-141998-01-13Akzo Nobel N.V.Method and apparatus for predicting the presence of congenital and acquired imbalances and therapeutic conditions
US6898532B1 (en)1995-06-072005-05-24Biomerieux, Inc.Method and apparatus for predicting the presence of haemostatic dysfunction in a patient sample
US6321164B1 (en)1995-06-072001-11-20Akzo Nobel N.V.Method and apparatus for predicting the presence of an abnormal level of one or more proteins in the clotting cascade
US6429017B1 (en)*1999-02-042002-08-06BiomerieuxMethod for predicting the presence of haemostatic dysfunction in a patient sample
US6502040B2 (en)1997-12-312002-12-31Biomerieux, Inc.Method for presenting thrombosis and hemostasis assay data
EP1147423B1 (en)1999-02-042004-11-10bioMérieux, Inc.A method and apparatus for predicting the presence of haemostatic dysfunction in a patient sample
DE19938520A1 (en)*1999-08-132001-02-22Vascular Biotech Gmbh Process for quality control of the endothelial lining of native blood vessels or in the tissue laboratory of endothelialized, artificial or natural blood vessels and blood vessel valves, cardiac cavities and heart valves
US7179612B2 (en)2000-06-092007-02-20Biomerieux, Inc.Method for detecting a lipoprotein-acute phase protein complex and predicting an increased risk of system failure or mortality
US20040208786A1 (en)*2003-01-272004-10-21Kevy Sherwin V.Autologous coagulant produced from anticoagulated whole blood
CA2623142C (en)*2004-09-222016-01-19The Regents Of The University Of Colorado, A Body CorporateMethods for a global assay of coagulation and fibrinolysis
US7735494B2 (en)2006-03-032010-06-15Xerosmoke, LlcTabacco smoking apparatus
CN107250375A (en)2014-11-062017-10-13科罗拉多州立大学董事会In the presence of thrombolytic agent new morbid state is identified using viscoelasticity analysis
US11143659B2 (en)2015-01-272021-10-12Arterez, Inc.Biomarkers of vascular disease
WO2016200765A1 (en)2015-06-082016-12-15The Regents Of The University Of Colorado, A Body CorporateTime independent viscoelastic analysis parameter for prediction of patient outcome
EP3455366A4 (en)2016-05-112020-02-26Michael P. Chapman VISCOELASTIC ANALYSIS OF PATIENTS WITH DISEASES RELATED TO THE CARDIOVASCULAR SYSTEM
CA3029905C (en)*2016-07-122021-11-30EMULATE, Inc.Uses of microfluidic devices comprising additive channels

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US4097238A (en)*1977-06-031978-06-27Ashley Sheldon JMethod of analyzing blood plasma clotting
US4695956A (en)*1984-11-011987-09-22Leveen Eric GApparatus and method of quantifying hemostasis using oscillations from a transducer immersed in the blood sample
US4979959A (en)*1986-10-171990-12-25Bio-Metric Systems, Inc.Biocompatible coating for solid surfaces
DE3739247C2 (en)*1987-11-191996-11-21Dade Int Inc Bleeding time measuring device
IE67430B1 (en)*1988-06-241996-04-03Res Corp Technologies IncAssay for soluble crosslinked fibrin polymers
SE464135B (en)*1989-07-141991-03-11Kabivitrum Ab PROCEDURE FOR DETERMINING THE FUNCTIONAL ACTIVITY OF FREE PROTEIN S OR PROTEIN C IN A PLASMA TEST
NO922247L (en)*1991-07-031993-01-04Hafslund Nycomed As BILATERAL AND UNILATERAL BLOOD CREAM COLLECTION INSTALLATION IN SOME STENOSED BLOCKS, WITH MIXING DEVICE

Also Published As

Publication numberPublication date
US6156530A (en)2000-12-05
WO1996014581A1 (en)1996-05-17
EP0870200A1 (en)1998-10-14
JPH10509514A (en)1998-09-14

Similar Documents

PublicationPublication DateTitle
SE9403833D0 (en) Analysis procedure and kit
DE3689856D1 (en) ANALYSIS METHOD AND DEVICE FOR BIOLOGICAL SPECIMES.
DK1141728T3 (en) Detection of kidney disease and treatment thereof
DE69832628D1 (en) RECOMBINANT RABBIT FACTOR BASED PROTHROMBIN TIME REAGENT
TR200000565T2 (en) Method for rapid analysis of analysis components in biological samples
SE9504046D0 (en) Method of determining affinity and kinetic properties
DK0947585T3 (en) Improved in vitro method, kits and reagents for screening for blood clotting defects
DK0486515T3 (en) A method for determining the functional activity of free protein S or protein C in a plasma sample
DE3788762D1 (en) Method for the determination of physiologically active substances.
ATE188292T1 (en) METHOD FOR DETECTING MARIJUANA IN A HAIR SAMPLE
DK492185D0 (en) SCREENING TEST FOR REVERSE-TRANSCRIPT-CONTAINING VIRUS
MX9804305A (en)Factor v ratio blood test for susceptibility to thromboembolism.
ATE67602T1 (en) ANALYSIS ELEMENT FOR DETERMINING COAGAGING PARAMETERS.
EA199900138A1 (en) DETECTION OF MAMMALIAN HEPARANASE ACTIVITY AND MAMMALIAN HEPARANASE PURIFICATION
DK0696642T3 (en) Method for detecting disorders in the protein C / protein S system
NZ332641A (en)method of detecting a lysosomal storage disorder by assaying the level of an enzyme, protein or peptide associated with the disease
ATE239918T1 (en) METHOD FOR IN-VITRO ANALYSIS OF TOXIC AND ALLERGENIC SUBSTANCES
DK0791073T3 (en) Analysis Method
MX9604417A (en) ANALYTE DETECTION.
ATE365321T1 (en) METHOD FOR DETECTING INFLAMMATION AND INFLAMMATORY CONDITIONS
EP1666612A3 (en)Method for determining the activity of a substance using a functional test in vitro
ES2168509T3 (en) PROCEDURES FOR IN VITRO DETERMINATION OF THE BIOACTIVITY OF ERYTHROPOYETIN.
DE60024923D1 (en) Method for analyzing the functional activation of leukocytes, platelets and other cells
ES8500457A1 (en)A Method of Determining the Oxidizing Activity of a Biological Liquid, and a Mammalian Lens- derived Reagent for use in the Method
DE69520725D1 (en) Procedure for the diagnosis of blood clotting disorders
[8]ページ先頭
©2009-2025 Movatter.jp